Repair of acne scars with Dermicol-P35.
Acne vulgaris is a prevalent skin condition that can cause disfiguring residual scarring. While the complete removal of acne scars is unlikely, several treatments exist that can improve the appearance of acne scars. Dermal fillers offer a simple, nonsurgical corrective procedure that can provide improved skin texture. Dermicol-P35 (Evolence [Ortho Dermatologics, Skillman, NJ]) is a new, highly purified, ribose cross-linked, porcine collagen-based dermal filler that has demonstrated low immunogenicity and results that persist for at least 12 months. This article presents the aesthetic results of a male patient treated with Dermicol-P35 for severe facial acne scars.
Smith
Kevin C
KC
Niagara Falls Dermatology and Skin Care Center Ltd, Niagara Falls, ON, Canada. ksmithderm@gmail.com
D000152:Acne Vulgaris / Q000150:complications*; D000818:Animals; D001672:Biocompatible Materials; D002921:Cicatrix / Q000209:etiology / Q000628:therapy*; D003094:Collagen / Q000008:administration & dosage* / Q000737:chemistry; D003357:Cosmetic Techniques; D003432:Cross-Linking Reagents / Q000737:chemistry; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000737:chemistry; D006031:Glycosylation; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D012060:Rejuvenation; D012266:Ribose / Q000737:chemistry; D013552:Swine; D013997:Time Factors; D016896:Treatment Outcome
D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; D003879:Dermatologic Agents; C530016:dermicol-P35 30G; D012266:Ribose; D003094:Collagen